We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.6B
AUM Growth
-$392M
Cap. Flow
-$203M
Cap. Flow %
-12.69%
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74

Top Buys

1
DGX icon
Quest Diagnostics
DGX
+$24.5M
2
CHD icon
Church & Dwight Co
CHD
+$19.6M
3
ES icon
Eversource Energy
ES
+$18.2M
4
EXPE icon
Expedia Group
EXPE
+$17.6M
5
KMB icon
Kimberly-Clark
KMB
+$17.5M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
CAG icon
Conagra Brands
CAG
+$27M
3
SEE
Sealed Air
SEE
+$22.8M
4
LLY icon
Eli Lilly
LLY
+$22.1M
5
REG icon
Regency Centers
REG
+$20.3M

Sector Composition

1 Healthcare 28%
2 Consumer Staples 25.89%
3 Communication Services 10.3%
4 Technology 7.09%
5 Materials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRE
301
DELISTED
Duke Realty Corp.
DRE
$110K 0.01%
+1,999
New +$109K
BLK icon
302
Blackrock
BLK
$167B
$109K 0.01%
+179
New +$117K
STT icon
303
State Street
STT
$51B
$109K 0.01%
1,763
– –
ANSS
304
DELISTED
Ansys
ANSS
$108K 0.01%
+451
New +$119K
ROK icon
305
Rockwell Automation
ROK
$51.5B
$108K 0.01%
544
+245
+82% +$55.3K
ANET icon
306
Arista Networks
ANET
$209B
$107K 0.01%
4,560
– –
JKHY icon
307
Jack Henry & Associates
JKHY
$10.9B
$106K 0.01%
589
+234
+66% +$43.8K
IRM icon
308
Iron Mountain
IRM
$36.2B
$103K 0.01%
2,107
+668
+46% +$35.2K
INCY icon
309
Incyte
INCY
$23.8B
$102K 0.01%
1,337
+445
+50% +$33.8K
CRWD icon
310
CrowdStrike
CRWD
$210B
$101K 0.01%
2,396
– –
CDW icon
311
CDW
CDW
$17.2B
$100K 0.01%
633
– –
COO icon
312
Cooper Companies
COO
$14.2B
$100K 0.01%
1,280
+356
+39% +$31.5K
SUI icon
313
Sun Communities
SUI
$15.1B
$99K 0.01%
+622
New +$104K
TPR icon
314
Tapestry
TPR
$28.9B
$99K 0.01%
3,236
+1,534
+90% +$50.2K
GPC icon
315
Genuine Parts
GPC
$17.3B
$98K 0.01%
737
+294
+66% +$39.1K
HBAN icon
316
Huntington Bancshares
HBAN
$37.5B
$98K 0.01%
8,165
– –
ESS icon
317
Essex Property Trust
ESS
$19.1B
$97K 0.01%
370
– –
KMX icon
318
CarMax
KMX
$8.2B
$97K 0.01%
1,070
+371
+53% +$34.9K
WPC icon
319
W.P. Carey
WPC
$16.9B
$97K 0.01%
1,190
+845
+245% +$68.2K
ALGN icon
320
Align Technology
ALGN
$12.6B
$95K 0.01%
+401
New +$123K
CCJ icon
321
Cameco
CCJ
$37.2B
$93K 0.01%
4,452
-114,227
-96% -$2.88M
AJG icon
322
Arthur J. Gallagher & Co
AJG
$65.9B
$90K 0.01%
+550
New +$91.3K
MFC icon
323
Manulife Financial
MFC
$72.2B
$90K 0.01%
5,174
+1,866
+56% +$35.3K
IT icon
324
Gartner
IT
$9.46B
$87K 0.01%
358
– –
MKL icon
325
Markel Group
MKL
$24.8B
$87K 0.01%
+67
New +$91.9K
11 12
13
14 15

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2022 Portfolio in Review

As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.

  • TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
  • TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
  • TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
  • TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
  • TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
  • TOBAM opened 74 new positions and closed 74 in Q2 2022.
  • TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.